Biotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to Market REDWOOD CITY, Calif., April 12, 2017 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative,...

Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...

biotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to Commercialization REDWOOD CITY, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- biotricity inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...

Biotricity Files for FDA 510(k) REDWOOD CITY, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative,...